These risks in humans are unknown, but retatrutide is contraindicated for individuals with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Cagrilintide is listed for professional research use with an emphasis on documentation, compound identification, research applications, storage awareness, and third-party testing transparency
Backed by Phase III trials showing roughly a 15% reduction in visceral fat
How long will I need to take these injections
The sequence includes two cysteine residues that form a disulfide bond, creating a constrained loop structure important for biological activity
Capsule endoscopy During capsule endoscopy, the patient swallows a pill-sized camera that collects photographs through the digestive tract